Emerging Landscape of Nanobodies and Their Neutralizing Applications against SARS-CoV-2 Virus
Author:
Affiliation:
1. Department of Microbiology and Immunology, College of Medicine and Health Science, China Three Gorges University, Yichang 443002, China
2. Institute of Cell Engineering, School of Medicine, Johns Hopkins University, Baltimore 21215, United States
Publisher
American Chemical Society (ACS)
Subject
Pharmacology (medical),Pharmacology
Link
https://pubs.acs.org/doi/pdf/10.1021/acsptsci.3c00042
Reference98 articles.
1. COVID-19-associated acute respiratory distress syndrome: is a different approach to management warranted?
2. Model-informed COVID-19 vaccine prioritization strategies by age and serostatus
3. Neutralising antibody escape of SARS‐CoV‐2 spike protein: Risk assessment for antibody‐based Covid‐19 therapeutics and vaccines
4. Breakthrough Infections in BNT162b2-Vaccinated Health Care Workers
5. Vaccine Breakthrough Infections with SARS-CoV-2 Variants
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Emerging Landscape of Mesenchymal Stem Cell Senescence Mechanisms and Implications on Therapeutic Strategies;ACS Pharmacology & Translational Science;2024-07-17
2. In Silico Analyses Indicate a Lower Potency for Dimerization of TLR4/MD-2 as the Reason for the Lower Pathogenicity of Omicron Compared to Wild-Type Virus and Earlier SARS-CoV-2 Variants;International Journal of Molecular Sciences;2024-05-17
3. Next generation single-domain antibodies against respiratory zoonotic RNA viruses;Frontiers in Molecular Biosciences;2024-05-09
4. Multifunctional Self-Signaling nanoMIP and Its Application for a Washing-Free Assay of Human Angiotensin-Converting Enzyme 2;Analytical Chemistry;2024-04-26
5. Engineered Multivalent Nanobodies Efficiently Neutralize SARS-CoV-2 Omicron Subvariants BA.1, BA.4/5, XBB.1 and BQ.1.1;Vaccines;2024-04-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3